dexamed 4 mg/ml soluţie injectabilă
medochemie ltd - dexamethasonum - soluţie injectabilă - 4 mg/ml
dexagel 0,985 mg/g
dr. gerhard mann chem-pharm. fabrik gmbh - germania - dexamethasonum - gel oft. - 0,985 mg/g - antiinflamatoare corticosteroizi
nexpovio
stemline therapeutics b.v. - selinexor - mielom multiplu - agenți antineoplazici - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
etacortilen 1,5 mg/ml
sifi s.p.a. - italia - dexamethasonum - pic. oft., sol. - 1,5mg/ml - antiinflamatoare corticosteroizi
ninlaro
takeda pharma a/s - citrat de ixazomib - mielom multiplu - agenți antineoplazici - ninlaro în asociere cu lenalidomidă și dexametazonă este indicat pentru tratamentul pacienților adulți cu mielom multiplu care au primit cel puțin o terapie anterioară.
bortezomib dr. reddy's 3,5 mg
betapharm arzneimittel gmbh - germania - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib cadmed 3,5 mg
pharmidea sia - lituania - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib krka 1 mg
krka, d.d., novo mesto - slovenia - bortezomibum - pulb. pt. sol. inj. - 1mg - alte antineoplazice inhibitori de proteazom
bortezomib krka 3,5 mg
krka, d.d., novo mesto - slovenia - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib stada 2,5 mg/ml
stada arzneimittel ag - germania - bortezomibum - sol. inj. - 2,5mg/ml - alte antineoplazice inhibitori de proteazom